Artiva Biotherapeutics Inc
NASDAQ:ARTV
Artiva Biotherapeutics Inc
NASDAQ:ARTV
Price:
5.32
USD
-3.62%
Market Closed
Market Cap:
$130.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Artiva Biotherapeutics Inc
NASDAQ:ARTV
|
US |
|
A
|
Alkhorayef Water and Power Technologies Company SCJSC
SAU:2081
|
SA |
|
C
|
CKX Lands Inc
AMEX:CKX
|
US |
|
Maan Aluminium Ltd
NSE:MAANALU
|
IN |
|
Indianivesh Ltd
BSE:501700
|
IN |
|
Patanjali Foods Ltd
NSE:PATANJALI
|
IN |
Income Statement
Earnings Waterfall
Artiva Biotherapeutics Inc
Artiva Biotherapeutics Inc
Income Statement
Artiva Biotherapeutics Inc
Artiva Biotherapeutics Inc
Currency: USD
| Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue |
34
N/A
|
0
-99%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||
| Operating Expenses |
(113)
|
(68)
|
(74)
|
(81)
|
(86)
|
(90)
|
|
| Selling, General & Administrative |
(26)
|
(17)
|
(19)
|
(20)
|
(20)
|
(20)
|
|
| Research & Development |
(87)
|
(50)
|
(56)
|
(62)
|
(66)
|
(70)
|
|
| Operating Income |
(79)
N/A
|
(67)
+15%
|
(74)
-11%
|
(81)
-9%
|
(86)
-6%
|
(90)
-4%
|
|
| Pre-Tax Income | |||||||
| Interest Income Expense |
6
|
5
|
7
|
7
|
7
|
6
|
|
| Total Other Income |
(4)
|
(3)
|
(3)
|
(1)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(78)
N/A
|
(65)
+16%
|
(71)
-9%
|
(75)
-5%
|
(79)
-6%
|
(84)
-6%
|
|
| Net Income | |||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(78)
|
(65)
|
(71)
|
(75)
|
(79)
|
(84)
|
|
| Net Income (Common) |
(78)
N/A
|
(65)
+16%
|
(71)
-9%
|
(75)
-5%
|
(79)
-6%
|
(84)
-6%
|
|
| EPS (Diluted) |
-4.08
N/A
|
-5.81
-42%
|
-2.93
+50%
|
-3.06
-4%
|
-3.25
-6%
|
-3.43
-6%
|
|
Switch to:
Switch to:
See Also
Discover More
